Dr. Betsy Garofalo has been named as the global therapy area leader for CNS, Astellas Pharma Global Development. Dr. Garofalo is a pediatric neurologist and epileptologist and has more than 17 years of drug development experience. “Betsy’s charge as head of the global therapy area is to provide strategic direction and leadership for the development of all Astellas CNS compounds,” said Dr. Steven Ryder, president of APGD. Betsy’s deep experience in CNS disorders and pas...